Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis
NCT ID: NCT00646867
Last Updated: 2008-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
44 participants
INTERVENTIONAL
2008-02-29
2008-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Tetrix Cream in the Healing of Injured Skin in Subjects With Contact Dermatitis
NCT00643214
Evaluation of Tetrix Cream as a Protective Barrier Against Injurious Materials
NCT00643630
Study to Determine if Tetrix Cream is Removed From the Hands by Gentle Washing With Soap and Water
NCT00644436
A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants
NCT04882631
A Study to Evaluate the Irritation Potential of ATx201 in Healthy Volunteers
NCT03301870
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Experimental
Tetrix
Twice daily topical application
2
Placebo
Placebo
Twice daily topical application
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tetrix
Twice daily topical application
Placebo
Twice daily topical application
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subjects with hand eczema
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Coria Laboratories, Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Coria Laboratories, Ltd.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joseph Fowler, MD
Role: PRINCIPAL_INVESTIGATOR
Dermatology Specialists, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dermatology Specialists, LLC
Louisville, Kentucky, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
805 806 09 004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.